Brentuximab Vedotin-Induced CIDP-Like Inflammatory Demyelinating Polyradiculoneuropathy (Clinical Case Report)
Brentuximab vedotin-induced inflammatory demyelinating polyradiculoneuropathy is a rare chemotherapy side effect. The underlying cause of disease is thought to be pathological drug effects on the humoral immune system. The typical clinical picture is characterized by progressive development of flaccid tetraparesis and...